Stephan R. Orth

5.6k total citations · 1 hit paper
57 papers, 4.2k citations indexed

About

Stephan R. Orth is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stephan R. Orth has authored 57 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Nephrology, 24 papers in Cardiology and Cardiovascular Medicine and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stephan R. Orth's work include Chronic Kidney Disease and Diabetes (19 papers), Blood Pressure and Hypertension Studies (13 papers) and Renin-Angiotensin System Studies (12 papers). Stephan R. Orth is often cited by papers focused on Chronic Kidney Disease and Diabetes (19 papers), Blood Pressure and Hypertension Studies (13 papers) and Renin-Angiotensin System Studies (12 papers). Stephan R. Orth collaborates with scholars based in Germany, Switzerland and United States. Stephan R. Orth's co-authors include Eberhard Ritz, Stein Hallan, Kerstin Amann, Christiane Viedt, Etsuro Ogata, Stian Lydersen, Kurt Kvenild, Solfrid Romundstad, Jörg Kreuzer and Eberhard Ritz and has published in prestigious journals such as New England Journal of Medicine, Kidney International and Hypertension.

In The Last Decade

Stephan R. Orth

57 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nephropathy in Patients with Type 2 Diabetes Mellitus

1999 593 citations Eberhard Ritz, Stephan R. Orth profile →

Peers

Countries citing papers authored by Stephan R. Orth

Since Specialization

Citations

This map shows the geographic impact of Stephan R. Orth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan R. Orth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan R. Orth more than expected).

Fields of papers citing papers by Stephan R. Orth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan R. Orth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan R. Orth. The network helps show where Stephan R. Orth may publish in the future.

Co-authorship network of co-authors of Stephan R. Orth

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan R. Orth. A scholar is included among the top collaborators of Stephan R. Orth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan R. Orth. Stephan R. Orth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Traditional and Nontraditional Cardiovascular Risk Factors and Estimated Risk for Coronary Artery Disease in Renal Transplant Recipients: A Single-Center Experience 2011 ·Nephron Clinical Practice ·Miriam C. Banas, Bernhard Banas, Stephan R. Orth, (unknown), Stephan W. Reinhold, Christian Weingart, Bettina Jung, Bernd Krüger, Bernhard K. Krämer	10
2	The Conundrum of Chronic Kidney Disease Classification and End-Stage Renal Risk Prediction in the Elderly – What Is the Right Approach? 2010 ·Nephron Clinical Practice ·Stein Hallan, Stephan R. Orth	30
3	Smoking behaviour of patients before and after renal transplantation 2007 ·Nephrology Dialysis Transplantation ·Miriam C. Banas, Bernhard Banas, J. Stuart Wolf, Uwe Reuter, (unknown), Carsten A. Böger, Stephan R. Orth, Bernhard K. Krämer	26
4	Blood Pressure-Independent Effect of Long-Term Treatment with the Soluble Heme-Independent Guanylyl Cyclase Activator HMR1766 on Progression in a Model of Noninflammatory Chronic Renal Damage 2007 ·Kidney & Blood Pressure Research ·Kerstin Benz, Stephan R. Orth, (unknown), Wolfgang Linz, Ursula Schindler, Hartmut Rütten, Kerstin Amann	25
5	Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus 2005 ·Nephrology Dialysis Transplantation ·Stephan R. Orth, (unknown), Eberhard Ritz, Paolo Ferrari	53
6	Smoking and dialysis: A dreadful scenario for the cardiovascular system? 2003 ·Kidney International ·Stephan R. Orth, Dominik E. Uehlinger	4
7	Beneficial Effects of Calcimimetics on Progression of Renal Failure and Cardiovascular Risk Factors 2003 ·Journal of the American Society of Nephrology ·Etsuro Ogata, Eberhard Ritz, (unknown), Kerstin Amann, Stephan R. Orth	119
8	Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertension 2003 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Moriz Buzello, (unknown), Stephan R. Orth, Bernhard Fischer, Heimo Ehmke, Eberhard Ritz, Gerhard Mall, Kerstin Amann	20
9	The renal risks of smoking: an update 2002 ·Current Opinion in Nephrology & Hypertension ·Stephan R. Orth, Eberhard Ritz	61
10	Cigarette smoke condensate aggravates renal injury in the renal ablation model 2002 ·Kidney International ·(unknown), Etsuro Ogata, Christiane Viedt, Kerstin Amann, Eberhard Ritz, Stephan R. Orth	50
11	Combination treatment with an ETA-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat models 2002 ·Nephrology Dialysis Transplantation ·Stephan R. Orth	13
12	Glomerulosclerosis and progression: Effect of subantihypertensive doses of α and βblockers 2001 ·Kidney International ·Kerstin Amann, (unknown), (unknown), Marie‐Luise Gross, Christian Haas, Stephan R. Orth, (unknown), Lars Christian Rump, Eberhard Ritz	85
13	Sympathetic overactivity and arterial hypertension in renal failure 2001 ·Nephrology Dialysis Transplantation ·Stephan R. Orth, Kerstin Amann, (unknown), Eberhard Ritz	49
14	Pharmacological intervention in progressive renal diseases 2001 ·Nephrology Dialysis Transplantation ·Stephan R. Orth, Michael Schömig, E. Ritz	4
15	Smoking – A Renal Risk Factor 2000 ·The Nephron journals/Nephron journals ·Stephan R. Orth	79
16	Adult Human Mesangial Cells (HMCs) Express Endothelin-B-Receptors which Mediate Endothelin-1-Induced Cell Growth 2000 ·Journal of Cardiovascular Pharmacology ·Stephan R. Orth, Kerstin Amann, (unknown), Liliane Unger, Jürgen Wagner, Manfred Raschack, Eberhard Ritz	22
17	The ETA Receptor Blocker LU 135252 Prevents Chronic Transplant Nephropathy in the “Fisher to Lewis” Model 1999 ·Journal of the American Society of Nephrology ·Stephan R. Orth, (unknown), Kerstin Amann, Piotr Strzelczyk, Manfred Raschack, Eberhard Ritz	52
18	Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats 1998 ·Kidney International ·(unknown), Kerstin Amann, Stephan R. Orth, (unknown), Sabine Wessels, Eberhard Ritz	200
19	Das nephrotische Syndrom 1998 ·Der Internist ·Stephan R. Orth, Eberhard Ritz	3
20	Systemic hypertension versus intraglomerular hypertension in progression 1994 ·Kidney International ·Eberhard Ritz, Stephan R. Orth, Thomas Weinreich, (unknown)	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact